Prestige Consumer Healthcare Inc (PBH)
84.14
+1.47
(+1.78%)
USD |
NYSE |
Nov 21, 16:00
84.19
+0.05
(+0.06%)
After-Hours: 20:00
Prestige Consumer Healthcare Enterprise Value: 5.157B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 5.157B |
| November 20, 2024 | 5.084B |
| November 19, 2024 | 5.074B |
| November 18, 2024 | 5.026B |
| November 15, 2024 | 5.069B |
| November 14, 2024 | 5.090B |
| November 13, 2024 | 5.067B |
| November 12, 2024 | 5.033B |
| November 11, 2024 | 5.039B |
| November 08, 2024 | 4.971B |
| November 07, 2024 | 4.957B |
| November 06, 2024 | 4.836B |
| November 05, 2024 | 4.694B |
| November 04, 2024 | 4.646B |
| November 01, 2024 | 4.659B |
| October 31, 2024 | 4.646B |
| October 30, 2024 | 4.637B |
| October 29, 2024 | 4.635B |
| October 28, 2024 | 4.640B |
| October 25, 2024 | 4.611B |
| October 24, 2024 | 4.601B |
| October 23, 2024 | 4.569B |
| October 22, 2024 | 4.547B |
| October 21, 2024 | 4.525B |
| October 18, 2024 | 4.587B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.575B |
| October 16, 2024 | 4.556B |
| October 15, 2024 | 4.523B |
| October 14, 2024 | 4.465B |
| October 11, 2024 | 4.440B |
| October 10, 2024 | 4.382B |
| October 09, 2024 | 4.376B |
| October 08, 2024 | 4.367B |
| October 07, 2024 | 4.339B |
| October 04, 2024 | 4.403B |
| October 03, 2024 | 4.378B |
| October 02, 2024 | 4.460B |
| October 01, 2024 | 4.502B |
| September 30, 2024 | 4.565B |
| September 27, 2024 | 4.591B |
| September 26, 2024 | 4.593B |
| September 25, 2024 | 4.565B |
| September 24, 2024 | 4.582B |
| September 23, 2024 | 4.639B |
| September 20, 2024 | 4.676B |
| September 19, 2024 | 4.720B |
| September 18, 2024 | 4.701B |
| September 17, 2024 | 4.702B |
| September 16, 2024 | 4.708B |
| September 13, 2024 | 4.730B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.156B
Minimum
Mar 23 2020
5.157B
Maximum
Nov 21 2024
4.100B
Average
4.186B
Median
Jun 21 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.273M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.38M |
| Revenue (Quarterly) | 283.78M |
| Total Expenses (Quarterly) | 199.45M |
| EPS Diluted (Quarterly) | 1.09 |
| Gross Profit Margin (Quarterly) | 55.46% |
| Profit Margin (Quarterly) | 19.16% |
| Earnings Yield | 4.88% |
| Operating Earnings Yield | 7.71% |
| Normalized Earnings Yield | 4.885 |